121 related articles for article (PubMed ID: 33460959)
1. Surrogate testing of oral third-generation cephalosporin susceptibility to common uropathogens.
Watson JR; Burch C; Leber AL
Diagn Microbiol Infect Dis; 2021 Apr; 99(4):115299. PubMed ID: 33460959
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of cefazolin as a surrogate marker for cefpodoxime susceptibility for urinary tract isolates.
Bookstaver DA; Bland CM; Arroyo MA
J Med Microbiol; 2015 Oct; 64(10):1170-1173. PubMed ID: 26219948
[TBL] [Abstract][Full Text] [Related]
3. [Susceptibility to first-generation Cephalosporins in Enterobacteriaceae isolated from urine culture according to CLSI and EUCAST breakpoints].
Corvalán V; Hervé B; Sanhueza C; Martínez N; Almonacid M; Fuente S
Rev Chilena Infectol; 2018; 35(3):329-331. PubMed ID: 30534916
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial resistance trends in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis urinary isolates from Switzerland: retrospective analysis of data from a national surveillance network over an 8-year period (2009-2016).
Zanichelli V; Huttner A; Harbarth S; Kronenberg A; Huttner B; Swiss Centre For Antibiotic Resistance Anresis
Swiss Med Wkly; 2019 Jul; 149():w20110. PubMed ID: 31340052
[TBL] [Abstract][Full Text] [Related]
5. [Pattern of antimicrobial susceptibility in uropathogen isolates from children].
Suárez VM; Suárez RC; Pérez BA; Alvarez FA; Castro SP; Rodríguez FS; Guerrero SM
Rev Esp Quimioter; 2001 Mar; 14(1):63-8. PubMed ID: 11376352
[TBL] [Abstract][Full Text] [Related]
6. Detection of TEM and CTX-M genes from ciprofloxacin resistant Proteus mirabilis and Escherichia coli isolated on urinary tract infections (UTIs).
Rajivgandhi G; Maruthupandy M; Manoharan N
Microb Pathog; 2018 Aug; 121():123-130. PubMed ID: 29778819
[TBL] [Abstract][Full Text] [Related]
7. [Emergence of resistance to third generation cephalosporins by Enterobacteriaceae causing community-onset urinary tract infections in hospitals in Colombia].
Leal AL; Cortés JA; Arias G; Ovalle MV; Saavedra SY; Buitrago G; Escobar JA; Castro BE;
Enferm Infecc Microbiol Clin; 2013 May; 31(5):298-303. PubMed ID: 22703702
[TBL] [Abstract][Full Text] [Related]
8. Emergence of New Delhi metallo-β-lactamase 1 (NDM-1) producing and multidrug resistant uropathogens causing urinary tract infections in Andaman Islands, India.
Bhattacharya D; Thamizhmani R; Bhattacharya H; Sayi DS; Muruganandam N; Roy S; Sugunan AP
Microb Drug Resist; 2013 Dec; 19(6):457-62. PubMed ID: 23862639
[TBL] [Abstract][Full Text] [Related]
9. Evolution of acquired resistance to third-generation cephalosporins in Enterobacteriaceae in a Tunisian hospital 1993-2001.
Boutiba-Ben Boubaker I; Ghozzi R; Ben Abdallah H; Mamlouk K; Kamoun A; Ben Redjeb S
Clin Microbiol Infect; 2004 Jul; 10(7):665-7. PubMed ID: 15214883
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of flomoxef and comparators against Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis producing extended-spectrum β-lactamases in China.
Yang Q; Zhang H; Cheng J; Xu Z; Xu Y; Cao B; Kong H; Ni Y; Yu Y; Sun Z; Hu B; Huang W; Wang Y; Wu A; Feng X; Liao K; Shen D; Hu Z; Chu Y; Lu J; Su J; Gui B; Duan Q; Zhang S; Shao H
Int J Antimicrob Agents; 2015 May; 45(5):485-90. PubMed ID: 25600890
[TBL] [Abstract][Full Text] [Related]
11. [Profile of antimicrobial resistance of agents causing urinary tract infections in children].
Ghedira Besbes L; Messaoudi A; Ben Meriem C; Guediche MN
Tunis Med; 2004 Mar; 82(3):299-305. PubMed ID: 15382465
[TBL] [Abstract][Full Text] [Related]
12. Effect of the 2014 Clinical and Laboratory Standards Institute urine-specific breakpoints on cefazolin susceptibility rates at a community teaching hospital.
Chastain DB; Ngando I; Bland CM; Franco-Paredes C; Hawkins WA
Ann Clin Microbiol Antimicrob; 2017 May; 16(1):43. PubMed ID: 28558707
[TBL] [Abstract][Full Text] [Related]
13. Comparative in vitro activity of cephalosporins.
Stewart D; Bodey GP
J Antibiot (Tokyo); 1976 Feb; 29(2):181-6. PubMed ID: 6411
[TBL] [Abstract][Full Text] [Related]
14. In Vitro Efficacy of Six Alternative Antibiotics against Multidrug Resistant Escherichia Coli and Klebsiella Pneumoniae from Urinary Tract Infections.
Chen YT; Ahmad Murad K; Ng LS; Seah JT; Park JJ; Tan TY
Ann Acad Med Singap; 2016 Jun; 45(6):245-50. PubMed ID: 27412057
[TBL] [Abstract][Full Text] [Related]
15. In-vitro activity of oral third-generation cephalosporins plus clavulanate against ESBL-producing Enterobacterales isolates from the MERINO trial.
Stewart AG; Bauer MJ; Butkiewicz D; Hinton A; Henderson A; Harris PNA; Paterson DL
Int J Antimicrob Agents; 2023 Aug; 62(2):106858. PubMed ID: 37211261
[TBL] [Abstract][Full Text] [Related]
16. Comparative Genomics of Antibiotic-Resistant Uropathogens Implicates Three Routes for Recurrence of Urinary Tract Infections.
Thänert R; Reske KA; Hink T; Wallace MA; Wang B; Schwartz DJ; Seiler S; Cass C; Burnham CA; Dubberke ER; Kwon JH; Dantas G
mBio; 2019 Aug; 10(4):. PubMed ID: 31455657
[TBL] [Abstract][Full Text] [Related]
17. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). I. Susceptibility distribution].
Kumamoto Y; Tsukamoto T; Matsukawa M; Kunishima Y; Hirose T; Shigeta S; Yamaguti O; Ishibashi K; Suzutani T; Yoshida H; Imafuku Y; Murai M; Watanabe K; Kobayashi Y; Uchida H; Matsuda S; Sato S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Furuya N; Deguchi T; Ishihara S; Ooe H; Oka T; Kitamura M; Fukuhara Y; Kamidono S; Arakawa S; Kumon H; Monden K; Matsumoto T; Muratani T; Naito S; Egashira T; Konishi T; Kohno S; Hirakata Y; Kondo A; Matsuda J; Nakano M
Jpn J Antibiot; 2006 Jun; 59(3):177-200. PubMed ID: 16913404
[TBL] [Abstract][Full Text] [Related]
18. beta-Lactamases responsible for resistance to expanded-spectrum cephalosporins in Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis isolates recovered in South Africa.
Pitout JD; Thomson KS; Hanson ND; Ehrhardt AF; Moland ES; Sanders CC
Antimicrob Agents Chemother; 1998 Jun; 42(6):1350-4. PubMed ID: 9624474
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility of recent bacterial isolates to cefdinir and selected antibiotics among children with urinary tract infections.
Bonsu BK; Shuler L; Sawicki L; Dorst P; Cohen DM
Acad Emerg Med; 2006 Jan; 13(1):76-81. PubMed ID: 16365328
[TBL] [Abstract][Full Text] [Related]
20. Ceftolozane/tazobactam activity tested against aerobic Gram-negative organisms isolated from intra-abdominal and urinary tract infections in European and United States hospitals (2012).
Sader HS; Farrell DJ; Flamm RK; Jones RN
J Infect; 2014 Sep; 69(3):266-77. PubMed ID: 24780763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
